Blog for Stock tips, Equity tips, Commodity tips, Forex tips: Sharetipsinfo.com

Want to beat the stock market volatility? Just keep on reading this exclusive blog by Sharetipsinfo which will cover topics related to stock market, share trading, Indian stock market, commodity trading, equity trading, future and options trading, options trading, nse, bse, mcx, forex and stock tips. Indian stock market traders can get share tips covering cash tips, future tips, commodity tips, nifty tips and option trading tips and forex international traders can get forex signals covering currency signals, shares signals, indices signals and commodity signals.

  UseFul Links:: Stock Market Tips Home | Services | Free Stock / Commodity Trial | Contact Us

Power Grid shares rise 4% on plans to launch Rs 7,700 crore InvIT IPO

http://sharetipsinfo.comJust get registered at Sharetipsinfo and earn positive returns

www.ShareTipsInfo.com

This is a big transaction and the size of the IPO is likely to be around Rs 7,700 crore, with a primary component of around Rs 4500 crores and the balance making up the secondary component. The price band is likely to be announced on April 29, sources said.

Representative image

Power Grid Corporation of India share price jumped over 4 percent in the morning session on April 23.

The electricity transmission company is preparing to launch the first ever InvIT (infrastructure investment trust) IPO by a state-owned firm, on April 29, marking a landmark deal for the Indian capital markets

The move comes at a time when the government has set a disinvestment target of Rs 1.75 lakh crore for FY22 and is betting big on initial public offerings (IPOs) by Life Insurance Corporation and Air India IPOs, after coming up short in the previous financial year.

An InvIT is a collective investment scheme similar to a mutual fund, which enables direct investment of money from individual and institutional investors in infrastructure projects to earn a small portion of the income as return.

“ This is a big transaction and the size of the IPO is likely to be around Rs 7,700 crore, with a primary component of around Rs 4500 crores and the balance making up the secondary component. The price band is likely to be announced on April 29,” said one of the persons cited above.

The stock was trading at Rs 212.20, up Rs 8.60, or 4.22 percent at 09:46 hours. It has touched an intraday high of Rs 212.90 and an intraday low of Rs 203.65.On January 27, 2021, was the first to report the filing of the DRHP ( draft red herring prospectus ) with market regulator Sebi by Power Grid.

ICICI Securities, Axis Capital, Edelweiss Financial Services & HSBC Securities and Capital Markets are the investment banks working on the InvIT IPO according to the DRHP filed with Sebi. Law firms Cyril Amarchand Mangaldas and J Sagar Associates are the legal advisors.

Get Stock Market tips With High Accuracy

Trade Spotlight: What should investors do with Apollo Hospitals, Cadila Healthcare & Max Healthcare?

http://sharetipsinfo.comJust get registered at Sharetipsinfo and earn positive returns

www.ShareTipsInfo.com


Stocks like Apollo Hospitals rose over 4 percent, Cadila Healthcare rallied over 5 percent, and Max Healthcare witnessed profit booking after hitting a fresh 52-week high on Tuesday.


Indian markets registered a negative close for the second consecutive day in a row on Tuesday which pushed the Sensex below 48000 and Nifty50 below 14300 levels.

Selling pressure was seen in IT, FMCG, finance, and banking stocks. Pharma sector outperformed and the S&P BSE Healthcare index closed with gains of 1.2 percent on Tuesday.

Stocks like Apollo Hospitals rose over 4 percent, Cadila Healthcare rallied over 5 percent, and Max Healthcare witnessed profit booking after hitting a fresh 52-week high on Tuesday.

Here's what Mazhar Mohammad, Chief Strategist – Technical Research & Trading Advisory, Chartviewindia.in, recommends investors should do with these stocks when the market resumes trading today:

Apollo Hospitals: Hold

This counter appears to be in a multi-week consolidation phase as it is moving in a broader range of Rs 3284 – 2787 levels for the last 8 weeks.

Hence, for the further sustainable rally, it needs a breakout above Rs 3284 levels on a closing basis. In that scenario, a bigger target of Rs 3580 can be expected.

However, failure to get past Rs 3284 may force the bulls to give up some of the gains. Nevertheless, a dip close to Rs 3000 can be a good opportunity to create fresh longs.

For time being, traders are advised to hold with a stop below Rs 3181 on a closing basis whereas, a breakout above Rs 3284 can also be considered as a fresh buying opportunity for a target of Rs 3580.

Cadila Healthcare: Book Profits

This counter registered a new lifetime high with a test of Rs 560 registered in 2017. However, momentum on the weekly charts seems to be dwindling down with indecisive formations.

Hence, short-term traders should book profits, if this counter fails to register a sustainable close above Rs 560 by the end of this week.

Any weakness from current levels may drag it down towards Rs 535 which can be considered as a buying opportunity to create fresh long positions.

If it manages a sustainable close above Rs 560 levels, then based on long-term charts a higher target of Rs 670 can be projected over a period of time.

Max Health Care: Books Profits

This counter appears to be in a short-term consolidation phase as it is moving sideways between the range of Rs 237 – 212 levels.

Even in the last trading session, it managed to get past the said resistance point on an intraday basis but encountered selling pressure at the higher end of the range. Hence, failure to register a breakout above Rs 240 on a closing basis may drag it down towards Rs 220 where one can consider fresh long positions with a stop below Rs 217 on a closing basis.In case if it manages a close above Rs 240 then a higher target of Rs 270 can be expected. For the time being, traders will be better off to book profits and wait for either a dip towards Rs 220 or a breakout above Rs 240.

Read Also:- Get Share Market Tips With High Accuracy




Delhi oxygen crisis: High Court issues contempt notice to Inox

http://sharetipsinfo.comJust get registered at Sharetipsinfo and earn positive returns

www.ShareTipsInfo.com

On April 19, the Delhi High Court court directed Inox not to divert supplies from Delhi to other places.Delhi Chief Minister Arvind Kejriwal asked the Centre through a tweet to provide the supply of oxygen immediatelyDelhi Chief Minister Arvind Kejriwal asked the Centre through a tweet to provide the supply of oxygen immediately

In a fresh twist to the battle for oxygen between Delhi and the Centre, the Delhi High Court has issued a notice of contempt to the country's largest medical oxygen manufacturer Inox, citing non-compliance with the court order.

On April 19, the Delhi High Court court directed Inox not to divert supplies from Delhi to other places after a petition was filed on the matter. The counsel for the Delhi government has informed the court that the company has violated the court order and did not supply it to the state.

The High Court said: "We direct M/s Inox to honour its contract with the Delhi government and hospitals and continue to supply oxygen and restore 140 metric tonnes supply immediately." However, due to the non-compliance on this, the Delhi High Court has directed Inox managing director or owner to be present in the court on April 21.

On the other hand, the company supplied Oxygen to Delhi's GTB Hospital which was running short of oxygen last night. On April 29, Delhi Health Minister Satyendar Jain had said that GTB Hospital was running out of medical oxygen. Following this, an oxygen tanker reached the hospital at around 1:30 am on April 21, saving the lives of over 500 critical COVID-19 patients. On April 20, Delhi recorded the highest single-day spike in COVID-19 cases adding 28,395 cases. Though the state had sought 700 metric tonnes of oxygen per day from the Centre, it was allocated only 300 metric tonnes.

Delhi Chief Minister Arvind Kejriwal also asked the Centre through a tweet to provide the supply of oxygen immediately as the state is facing a serious shortage of gas. States like Maharashtra, Gujarat, Madhya Pradesh, Delhi and Uttar Pradesh are facing a heavy shortage of life-saving gas. Hospitals in these high-burden states are having a stock of only one day off oxygen compared to three days before.

 Get Best Intraday Trading Tips From Sharetipsinfo

Analysis: India shifts from mass vaccine exporter to importer, worrying the world

http://sharetipsinfo.comJust get registered at Sharetipsinfo and earn positive returns

www.ShareTipsInfo.com

On Thursday India reported 200,739 infections over the past 24 hours, a seventh daily record in the last eight days, while 1,038 deaths took its toll to 173,123. Its tally of 14.1 million infections is second only to the United States.FILE PHOTO: A health official draws a dose of the AstraZeneca's COVID-19 vaccine manufactured by the Serum Institute of India, at Infectious Diseases Hospital in Colombo, Sri Lanka January 29, 2021. REUTERS/Dinuka Liyanawatte/File Photo

Record PHOTO: A wellbeing official draws a portion of the AstraZeneca's COVID-19 immunization fabricated by the Serum Institute of India, at Infectious Diseases Hospital in Colombo, Sri Lanka January 29, 2021. REUTERS/Dinuka Liyanawatte/File Photo 


Subsequent to gifting and selling a huge number of COVID-19 immunization dosages abroad, India unexpectedly gets itself shy of shots as new contaminations flood on the planet's second-most crowded country. 

India penetrated 200,000 day by day diseases interestingly on Thursday, and is attempting to immunize a greater amount of its populace utilizing locally delivered shots. 

Confronting taking off cases and flooding medical clinics after lockdown limitations were facilitated, it likewise unexpectedly changed the guidelines to permit it to quick track immunization imports, having prior rebuked unfamiliar drugmakers like Pfizer. 

It will import Russia's Sputnik V immunization beginning this month to cover upwards of 125 million individuals. 

The inversion in fortunes could hamper not exclusively India's fight to contain the pandemic, yet additionally immunization crusades in excess of 60 more unfortunate nations, mostly in Africa, for quite a long time. 

The COVAX program, sponsored by the World Health Organization and Gavi antibody coalition, focuses on fair immunization access all throughout the planet, and is depending intensely on provisions from India, Asia's drug force to be reckoned with. 

However, so far this month India has just traded around 1.2 million antibody dosages. That contrasts and 64 million portions transported abroad between late January and March, as indicated by information from the unfamiliar service. 

An authority with information on India's antibody system said that accessible shots would be utilized locally while the nation confronted an "crisis circumstance". 

"There is no obligation to different nations," he said. 

India's unfamiliar service, which manages antibody manages different nations, said a week ago that Indian interest would direct the degree of fares. 

Coming about deficiencies are now being felt in certain nations in the COVAX conspire, and a U.N. wellbeing official associated with the immunization rollout in Africa said: "To be so dependent on one producer is a gigantic concern." 

The overseer of the Africa Centers for Disease Control and Prevention, John Nkengasong, said recently delays in provisions from India could be "calamitous". 

Four sources associated with conversations on immunization supplies and acquisition said factors remembering delays by India and COVAX for putting in firm requests, an absence of interest underway, crude material deficiencies and disparaging the Covid flood at home had added to antibody deficiencies. 

The Serum Institute of India (SII), the world's greatest immunization producer, had pledged to convey in any event 2 billion COVID-19 shots to low and center pay nations, with almost 50% of that before the finish of 2021. 

Yet, it has additionally felt obligated to address the issues of different governments, including Britain, Canada and Saudi Arabia, in the midst of AstraZeneca's worldwide creation issues. 

The United States, in the mean time, ring-fenced the inventory of key hardware and crude materials for its own immunization producers, restricting SII's tasks and deferring by months its objective of raising month to month yield to 100 million from up to 70 million presently, said one of the sources. 

A further beginning obstacle to SII's inventory desire was India's dithering in submitting firm requests, two sources said. 

That might have permitted it to help yield of the AstraZeneca immunization early, despite the fact that controllers presently couldn't seem to endorse it. 

India went through months examining the last cost per portion, and inked an underlying buy request approximately fourteen days after India's medication controller endorsed the AstraZeneca shot, as per the sources. 

At a certain point, SII ran out of space to store delivered dosages. 

"That is the reason I decided not to pack in excess of 50 million dosages, since I knew whether I stuffed more than that, I would need to store it in my home," SII Chief Executive Adar Poonawalla told Reuters in January. 

He said he had burned through 20 billion rupees ($272 million) on the 50 million portions that the organization began accumulating since around October. 

Indeed, even now, the public authority just makes specially appointed buys from SII as opposed to concurring a more extended term supply plan, said one of the sources. 

He  has looked for more than $400 million from the public authority to build limit, however no responsibility has yet been made. 

The wellbeing office and unfamiliar service didn't react to demands for input on issues of subsidizing, buying delays and different parts of India's immunization rollout. 

COVAX CONUNDRUM 

COVAX additionally didn't green-light shipments to partaking nations from SII until after the shot got WHO freedom in mid-February, said a source engaged with the COVAX activity. 

The source said those postpones implied a huge number of extra dosages that the SII might have created among October and February won't ever emerge. 

Gavi safeguarded its choice to sit tight for appropriate endorsements prior to proceeding with firm requests. And keeping in mind that it is searching for additional providers, it yielded that much actually relied upon India's antibody creators who represent some 60% of worldwide supplies. 

COVAX has an arrangement to purchase 1 billion or more portions from the SII. Be that as it may, it has gotten not exactly a fifth of the 100 million or so portions of the SII-made AstraZeneca immunization it had expected by May. SII is likewise expected to make a huge number of portions of the Novavax went for COVAX. 

Gavi had trusted SII would completely continue antibody conveyances to COVAX in May, yet on Wednesday it said India's COVID-19 emergency could influence that. 

"We comprehend the savagery of the infection in India at the current time, by and by we trust and anticipate that deliveries should continue quickly," it said in an email to Reuters. 

On Thursday India announced 200,739 diseases in the course of recent hours, a seventh day by day record over the most recent eight days, while 1,038 passings caused significant damage to 173,123. Its count of 14.1 million diseases is second just to the United States. 

Having initially expected to cover 300 million of its most noteworthy danger individuals by August, or a little more than a fifth of its 1.35 billion populace, the public authority has now extended that by another 100 million, with the guarantee to augment it further.


Read Also:- Stock Market Tips






Lockdown to have deep impact on Maharashtra economy: Industry bodies

http://sharetipsinfo.comJust get registered at Sharetipsinfo and earn positive returns

www.ShareTipsInfo.com

The Maharashtra government on Tuesday announced a 15-day statewide curfew from Wednesday amid the spike in coronavirus cases in the state. The curfew, which exempts essential services, will come into effect from 8 pm on Wednesday


Economy

Indian industry on Wednesday said imposition of stricter lockdown in Maharashtra will help slow the transmission of coronavirus but it will have a deep impact on the state's economy.

The Maharashtra government on Tuesday announced a 15-day statewide curfew from Wednesday amid the spike in coronavirus cases in the state. The curfew, which exempts essential services, will come into effect from 8 pm on Wednesday.

Industry has impressed upon the states that there must be no lockdown.

Industry body FICCI said it has interactions with the Maharashtra government and the chamber has shared inputs from its members both on policy and operational issues.

"We are certainly hopeful that this (restrictions) will help slow the transmission of the virus. However, the lockdown will have a deep impact on the state's economy and FICCI Maharashtra will engage deeply with the stakeholders in the government to minimise the impact and smoothen out the implementation related issues," Sulajja Firodia Motwani, chairperson of FICCI Maharashtra, said.

She said there are concerns on both supply and demand side. And, on the supply side, many companies operating in Maharashtra are selling their products all over the country and extended disruption in  their operation will create a negative impact on their customers, she added.

The closure of retail would impact the demand side, she said expressing hope that the lockdown should not be extended beyond April 30.

Industry body Assocham also said it is working with the Maharashtra government to mitigate the economic impact of its 15-day curfew, and urged all states to reach out to the most vulnerable sections of the industry, particularly in the informal sectors, with the best possible relief.

"We would continue to remain engaged with the central and the Maharashtra governments, in our efforts to mitigate the economic impact of the 15-day Jantata Curfew in the state.

"We have also urged the federal and states to reach out to the most vulnerable sections of the industry, particularly in the informal sectors, with the best possible relief," Assocham said in a statement.

It added that it has approached all the states and the Centre to provide liberal regulatory and financial forbearances for compliances.

Fixed charges like electricity dues, lease rentals, licence fees and other levies should be waived, to help businesses maintain continuity, it suggested. Restaurants, hotels, small eateries should be given financial support for retaining the manpower, while the formal sectors of the economy should be engaged for regulatory forbearances, Assocham added.

B Thiagarajan, chairman (western region) of CII, said the industry is abiding by standard operating procedures to ensure a safe working place for its workforce and also to ensure containment of the spread.

"Right from the beginning of the pandemic, CII has been involved in regular consultative meetings with the state government officials and also authorities at the district and municipal corporation levels to ensure that industry can operate without any interruption," 

he said.CII has been consistently making a strong point in favour of continuing industry operations smoothly while abiding by the procedures for the workplace. From time to time, it has urged the government that there should be no lockdown he  added

Read Also :- Share market Tips

Gold price today: Yellow metal gains momentum; buy for a target of Rs 46,700: Experts

http://sharetipsinfo.comJust get registered at Sharetipsinfo and earn positive returns

www.ShareTipsInfo.com

We suggest buying in gold around Rs 46300 with a stop loss of Rs 46100 for the target of Rs 46700, and in silver around Rs 65800 with a stop loss of Rs 65200 for the target of Rs 67000, suggest experts.

Source: Reuters

India Gold MCX June Futures trade higher on Tuesday after a negative close seen in the previous trading session. Experts advise investors to buy the yellow metal on dips for a target of Rs 46,700 per 10 gm while silver May futures is also a buy for a target of Rs 67,000 per kg.

On the Multi-Commodity Exchange (MCX), June gold contracts were trading higher by 0.14 percent at Rs 46,483 for 10 grams at 0935 hours. May silver futures were trading 0.26 percent higher at Rs 66,299 a kilogram.

Gold and silver fell for the second straight day on Monday amid technical selling after recent gains. Despite the steady dollar, middle-east tensions and correction in global equity markets weighed on precious metals.

Gold June futures contract settled at $1732.70 per troy ounce, and Silver May futures contract settled $24.87 per troy ounce. Both the precious metals settled on a weaker note in the domestic markets.

“COMEX gold trades little changed near $1732/oz after a 0.7% decline in the previous session. Weighing on gold is a pause in the US dollar’s recent slide, general optimism about the US and global economy and continuing investor outflows.

However, supporting price is rising virus cases, loose monetary policy stance of major central banks and mixed economic data from major economies. Gold has retreated after failing to sustain above $1750/oz but we may not see extended losses amid Fed's dovish stance and rising virus concerns,” he said.

In the domestic market, Gold June futures contract settled at Rs 46419 per 10 gram, and silver May futures contract settled at Rs 66128 per one kilogram.

Gold and silver prices fell once again on Monday despite a steady dollar, but experts feel that volatility is likely to continue but any dips could be used as a buying opportunity amid weakness in the rupee.

“We expect both the precious metals could find support at lower levels in today’s session. A weakness in the rupee could also support prices of both the precious metals,” Manoj Jain, Director (Head-Commodity & Currency Research) at Prithvi Finmart said.

“Gold has support at $1718-1700 per troy ounce and resistance is placed at $1744-1758 per troy ounce. Silver has support at $24.55-24.20 per troy ounce and resistance at $25.20-25.55 per troy ounce,” he said.

Jain added that at MCX, Gold has support at Rs 46180-46000 and resistance at Rs 46660-46850 and silver is having support at Rs 65800-65200 and resistance at Rs 66600-67300 levels. “We suggest buying in gold around Rs 46300 with a stop loss of Rs 46100 for the target of Rs 46700 and in silver around Rs 65800 with a stop loss of Rs 65200 for the target of Rs 67000,” he added.

Track Live Gold Prices here

Technical Indicators:

Analyst: Sriram Iyer, Senior Research Analyst at Reliance Securities

International gold and silver prices fell on Monday even as the dollar and the benchmark yields eased on Monday. Domestic gold and silver ended weaker on Monday, tracking the overseas prices.

Powell Comments and CPI uncertainty pressures prices. Powell said recently that a coming upswing in inflation readings is likely to be transitory and won’t cause the Fed to change monetary policy.

Domestic gold and silver prices could trade weak this Tuesday morning tracking overseas prices.

Technically, MCX Gold June supports are at Rs 46000 and Rs 46200. Resistances are at Rs 46550 and Rs 46800.Technically, MCX Silver May resistances are at Rs 66800 and Rs 67500. Supports are at Rs 65900 and Rs 64800.

Get live Intraday Trading Tips

Deploy Bank Nifty Modified Put Butterfly strategy: Shubham Agarwal

http://sharetipsinfo.comJust get registered at Sharetipsinfo and earn positive returns

www.ShareTipsInfo.com

Considering the continues long unwinding followed by short in the end of the week in the Bank Nifty, it is prudent to approach the Bank Nifty with low-risk strategy as Modified Put Butterfly.

Wide intra week swing was seen in Nifty in the previous week. Clever began the week with substantial choppiness losing around 2% in a solitary meeting. Pullback in the followed days assisted Nifty with recovering the degree of 15000 once more. 

Over the course of the week Nifty spun inside 14500-15000 level and finished the week down 0.5%. On the Nifty Fut. Open Interest (OI) side, OI Built-up was almost 5%. 

Bank Nifty was more compacted with the selling pressure throughout the week. Bank Nifty slipped right from 34000 to 32250 almost (1700 focuses), finishing the week at 32600 losing more than 4.5%. 

Taking a gander at the Nifty week after week expiry alternative information, imperative obstruction remains at 15000 level followed by the 15500 level. On the drawback, 14500 stands as prompt help level and Highest Put OI remains at 13500 level going about as the indispensable help on the lower side. 

Bank Nifty OI (Open Interest) information shows the more extensive territory for week after week expiry. Be that as it may, Call authors are more dynamic contrasted with Put journalists and seen adding position till 40000CE strike. Bank Nifty indispensable opposition remains at 33000 followed by 34000. 

As of now, Bank Nifty is exchanging at the imperative help level of 32500, further any OI Unwinding at this level could lead Bank Nifty to fall more, further help remains at 32000 level. 

India VIX has spiked more than 6% from 19.99 to 21.21. Notwithstanding, cool off in the IV from its undeniable level has given solidarity to Nifty. India VIX has declined bit by bit over the course of the week to 19.8 level from its high 21.2. VIX shut at the degree of 19.8 contrasted with 19.99 last Friday. 

Taking a gander at the nostalgic pointer, Nifty OIPCR for the week has declined from 1.358 to 1.288. Bank Nifty OIPCR over the course of the week, additionally declined from 0.88 to 0.72 contrasted with last Friday. Generally speaking information demonstrates higher Put journalists versus bring scholars over the course of the week for the Nifty and Bank Nifty. 

Moving further to the week by week commitment of areas to Nifty. IT has offered help by 133, trailed by peripheral help from Metal (40 focuses). Though PVT Bank drove the destruction by contributing - 225 focuses to Nifty. 

Looking towards the top gainer and washout loads of the week in the FnO section, JSW Steel beat by acquiring around 22%, trailed by Cadila Healthcare (17%), Lal Pathlab (16%). While UBL lost 11% followed by PVR and Bajaj Finance (- 7.5% each). 

End: Considering the proceeds with long loosening up followed by short toward the week's end in the Bank Nifty, it is reasonable to move toward the Bank Nifty with generally safe procedure as Modified Put Butterfly.

Get Indian Stock Market Tips at Sharetipsinfo.

These 5 Nifty stocks have surged over 50% in 2021, do you own any?

http://sharetipsinfo.comJust get registered at Sharetipsinfo and earn positive returns

www.ShareTipsInfo.com


These five stocks are trading way above their 200-daily moving average (DMA). Interesting fact, 46 out of Nifty50 companies are currently trading above their 200-DMA.


These five stocks are exchanging route over their 200-every day moving normal (DMA). Intriguing actuality, 46 out of Nifty50 organizations are presently exchanging over their 200-DMA. 

The Nifty has acquired around 6% so far in the schedule year 2021 however five stocks on the list have had a marvelous run, energizing in excess of 50% in a little more than a quarter of a year. Indeed, these five stocks are exchanging path over their 200-every day moving normal (DMA). On the off chance that a stock exchanges over its 200-DMA, the pattern is to a great extent upward however there can be a momentary descending development. From the rundown, Tata Motors is exchanging 12% beneath its 52-week excessive cost of Rs 357, while any remaining stocks are 4-7 percent away from their 52-week highs. (Information Source: ACE Equity). As per Sharetipsinfo SWOT investigation, these stocks, excepting Tata Motors, have a bigger number of qualities than shortcomings. 

Goodbye Motors Ltd. | The stock has risen 71% in 2021—from Rs 183.85 on December 31, 2020 to Rs 313.95 on April 8, 2021. The offer contacted its 52-week high of Rs 357 on March 3, 2021. 

Adani Ports and Special Economic Zone Ltd. | The stock has risen 70% in 2021—from Rs 483.75 on December 31, 2020 to Rs 823.00 on April 8, 2021. The offer contacted its 52-week high of Rs 885 on April 7, 2021. 

JSW Steel Ltd. | The stock has risen 59% in 2021—from Rs 387.20 on December 31, 2020 to Rs 614.10 on April 8, 2021. The offer contacted its 52-week high of Rs 639 on April 8, 2021. 

Grasim Industries Ltd. | The stock has risen 56% in 2021—from Rs 927.85 on December 31, 2020 to Rs 1447.80 on April 8, 2021. The offer contacted its 52-week high of Rs 1473 on April 5, 2021. 

Hindalco Industries Ltd. | The stock has risen 52% in 2021—from Rs 240.55 on December 31, 2020 to Rs 365.20 on April 8, 2021. The offer contacted its 52-week high of Rs 374 on April 8, 2021.

Get High Accuracy Share Market Tips From Sharetipsinfo


Share Market Closing Note

http://sharetipsinfo.comJust get registered at Sharetipsinfo and earn positive returns

www.ShareTipsInfo.com

Snapping their 3-day winning streak, domestic equity markets traded range-bound in the negative territory on Friday, with a few episodes of gains. Amid mixed global cues and record Covid-19 cases back home, coupled with reports of vaccine supply crunch, the benchmark indices dropped 0.3 per cent today.


Among headline indices, the S&P BSE Sensex ended the day at 49,591 level, down 155 points. 50 per cent of the constituents ended the day in the red with Bajaj Finance (down 3 per cent), Ultratech Cement, NTPC, ICICI Bank, Axis Bank, IndusInd Bank, and Reliance Industries leading the list of losers. On the upside, Sun Pharma, HUL, Tech Mahindra, Titan Company, Dr Reddys Labs, and HCL Tech were the top gainers on the index, up in the range of 1 per cent to 3.5 per cent.

On the NSE, the 50-share barometer settled at 14,835 levels, down 39 points dragged down by UPL, Tata Steel, Coal India, and Axis Bank.

Trends in the broader markets were mixed as the S&P BSE SmallCap index closed 0.7 per cent higher while the S&P BSE MidCap index dipped 0.07 per cent.

The SmallCap index hit fresh record peak of 21,667, for second day in a row on the back of gains in Srei Infra, Butterfly Gandhimathi, Kilitch Drugs, Subex, Bank of Maharashtra, Aarti Surfactants, Vimta Labs, and Sasken Technologies.  

--------------------------------------------------------------------------------------------

Topic :- Time:3.00 PM

Nifty spot if holds above 14800 level on closing basis then expect some further upmove in coming sessions and if it closes below above mentioned level then some sluggish movement is likely to follow in the market.

--------------------------------------------------------------------------------------------

Topic :- Time:2.40 PM

Just In:

PE fund True North Fund sells part stake in IPO bound Policybazaar: Buyers include Serum Institute.

--------------------------------------------------------------------------------------------

Topic :- Time:2.00 PM

Nifty declining. Nifty spot if breaks and trade below 14780 level then expect some further decline in the market and if it manages to trade and sustain above 14820 level then some upmove can follow in the market.

--------------------------------------------------------------------------------------------

Topic :- Time:1.00 PM

Nifty is still trading in a very small range. Nifty spot if breaks and trade below 14840 level then expect some decline in the market and if it manages to trade and sustain above 14880-14900 levels then some upmove is likely to be seen in the Nifty.

--------------------------------------------------------------------------------------------

Topic :- Time:12.00 PM

News Wrap Up:

1. Sensex, Nifty volatile; Nifty PSU Bank index surges 3%

2. After Facebook, LinkedIn faces massive 500 mn users data leak

3. Privatisation of two public sector banks on meeting agenda next week

4. SBI drags feet on loan to Adani firm for controversial Australian coal mine

5. No need for lockdown, focus on Covid-19 tests: PM Modi to CMs

6. GameStops strong stock performance triggered board directors exit

7. Zensar Tech climbs 6% on entering into a partnership with Claimatic

8. Siemens gains 4% on signing MoU with Ashok Leyland for E-Mobility solutions

9. Srei Infra zooms 20% as arm receives EoI for $250 mn capital infusion

10. Khadim India rises for fourth day, jumps 7% on credit rating tweak

--------------------------------------------------------------------------------------------

Topic :- Nifty Opening Note

Indian Stock Market Trading View For 09 April,2021:

Nifty to remain volatile. Nifty is likely to be sentiment driven.

Huge surge in Covid-19 cases along with looming lockdown fear can hamper sentiments.

Nifty spot if manages to trade and sustain above 14920 level then expect some upmove and if it breaks and trade below 14840 level then some decline can be seen in the market. Please note this is just opening view and should not be considered as the view for the whole day.

--------------------------------------------------------------------------------------------

Get 90% Accurate Stock Market tips & Share Market Tips


Tax planning: Check latest changes made in ITR forms

http://sharetipsinfo.comJust get registered at Sharetipsinfo and earn positive returns

www.ShareTipsInfo.com

Earlier, dividend income up to Rs 10 lakh was exempt from tax under Section 10(34). Taxpayers were required to show such income under the exempt income section.

The duty division said no huge changes were made for the current year because of the Covid pandemic while advising new personal assessment form (ITR) structures for evaluation year 2021-22 (AY22). 

In accordance with the adjustments in the Finance Act, 2020, there are sure changes that have been brought. Here are a portion of the Key changes you should know. 

The profit pay must be unveiled under "pay from different sources". In the Finance Act, 2020, profits were made available in the possession of the citizens rather than profit dispersion assessment to be deducted by the organization or installment or assertion of profit. 

"Until AY21, just profit pay that was not excluded was needed to be uncovered in the part 'pay from different sources'. Presently, a wide range of profit salaries are needed to be unveiled here," an expense research firm said in a Mint. 

Citizens were needed to show such pay under the excluded pay area. Prior, profit pay up to Rs 10 lakh was excluded from charge under Section 10(34). The reference to profit pay up to Rs 10 lakh from a homegrown firm has been taken out from the absolved pay area. 

Under Section 115BAC, the public authority presented another concessional charge system in FY20 that permits citizens the alternative to pay charge at lower chunk rates however swear off around 70 derivations. The citizen is needed to pick in the event that the person is choosing the concessional charge system under Section 115BAC in Part An of the tax documents.

Get Best Commodity Tips From Sharetipsinfo

  UseFul Links:: Stock Market Tips Home | Services | Free Stock / Commodity Trial | Contact Us